Why Bristol-Myers’ lung cancer drug could still succeed despite stunning trial failure
August 05, 2016 at 14:59 PM EDT
Trial failure was “possibly the biggest clinical surprise of my career,” an analyst wrote.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|